Ebrahimi-Fakhari D - Search Results

1

Deep brain stimulation for medically refractory status dystonicus in UBA5-related disorder.

Zaman Z, Straka N, Pinto AL, Srouji R, Tam A, Periasamy U, Stone S, Kleinman M, Northam WT, Ebrahimi-Fakhari D. Zaman Z, et al. Mov Disord. 2023 Sep;38(9):1757-1759. doi: 10.1002/mds.29428. Epub 2023 May 2. Mov Disord. 2023. PMID: 37130202 Free PMC article. No abstract available.

2

Molecular chaperones and co-chaperones in Parkinson disease.

Dimant H, Ebrahimi-Fakhari D, McLean PJ. Dimant H, et al. Neuroscientist. 2012 Dec;18(6):589-601. doi: 10.1177/1073858412441372. Epub 2012 Jul 24. Neuroscientist. 2012. PMID: 22829394 Free PMC article. Review.

3

[Stroke in children and adolescents].

Meyer S, Poryo M, Flotats-Bastardas M, Ebrahimi-Fakhari D, Yilmaz U. Meyer S, et al. Radiologe. 2017 Jul;57(7):569-576. doi: 10.1007/s00117-017-0265-4. Radiologe. 2017. PMID: 28589229 Review. German.

4

Emerging role of autophagy in pediatric neurodegenerative and neurometabolic diseases.

Ebrahimi-Fakhari D, Wahlster L, Hoffmann GF, Kölker S. Ebrahimi-Fakhari D, et al. Pediatr Res. 2014 Jan;75(1-2):217-26. doi: 10.1038/pr.2013.185. Epub 2013 Oct 28. Pediatr Res. 2014. PMID: 24165736 Review.

5

Clinical manifestations and longterm followup of a patient with CINCA/NOMID syndrome.

Ebrahimi-Fakhari D, Wahlster L, Mackensen F, Blank N. Ebrahimi-Fakhari D, et al. J Rheumatol. 2010 Oct;37(10):2196-7. doi: 10.3899/jrheum.100290. J Rheumatol. 2010. PMID: 20889617 No abstract available.

6

Proteotoxicity and cardiac dysfunction.

Ebrahimi-Fakhari D, McLean PJ, Wahlster L. Ebrahimi-Fakhari D, et al. N Engl J Med. 2013 May 2;368(18):1754. doi: 10.1056/NEJMc1302511. N Engl J Med. 2013. PMID: 23635069 No abstract available.

7

Studying protein degradation pathways in vivo using a cranial window-based approach.

Unni VK, Ebrahimi-Fakhari D, Vanderburg CR, McLean PJ, Hyman BT. Unni VK, et al. Methods. 2011 Mar;53(3):194-200. doi: 10.1016/j.ymeth.2010.12.032. Epub 2010 Dec 25. Methods. 2011. PMID: 21187150 Free PMC article.

8

Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss.

McFarland NR, Dimant H, Kibuuka L, Ebrahimi-Fakhari D, Desjardins CA, Danzer KM, Danzer M, Fan Z, Schwarzschild MA, Hirst W, McLean PJ. McFarland NR, et al. PLoS One. 2014 Jan 20;9(1):e86048. doi: 10.1371/journal.pone.0086048. eCollection 2014. PLoS One. 2014. PMID: 24465863 Free PMC article.

9

Recurrent Stroke-Like Episodes in FBXL4-Associated Early-Onset Mitochondrial Encephalomyopathy.

Ebrahimi-Fakhari D, Seitz A, Kölker S, Hoffmann GF. Ebrahimi-Fakhari D, et al. Pediatr Neurol. 2015 Dec;53(6):549-50. doi: 10.1016/j.pediatrneurol.2015.08.018. Epub 2015 Sep 3. Pediatr Neurol. 2015. PMID: 26421988 No abstract available.

10

Direct detection of alpha synuclein oligomers in vivo.

Dimant H, Kalia SK, Kalia LV, Zhu LN, Kibuuka L, Ebrahimi-Fakhari D, McFarland NR, Fan Z, Hyman BT, McLean PJ. Dimant H, et al. Acta Neuropathol Commun. 2013 May 9;1:6. doi: 10.1186/2051-5960-1-6. Acta Neuropathol Commun. 2013. PMID: 24252244 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters